文献

J-GLOBAL ID：201902287124219167   整理番号：19A0419406

肝硬変患者におけるプロトンポンプ阻害剤療法は血清エンドトキシン活性を上昇させない

Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis

著者 (27件)： Okura Yasushi (Department of Endoscopy, Nara Medical University Hospital, Nara, Japan) ,  Namisaki Tadashi (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Sato Shinya (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Moriya Kei (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Akahane Takemi (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Kitade Mitsuteru (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Kawaratani Hideto (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Kaji Kosuke (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Takaya Hiroaki (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Sawada Yasuhiko (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Shimozato Naotaka (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Seki Kenichiro (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Saikawa Soichiro (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Nakanishi Keisuke (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Furukawa Masanori (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Fujinaga Yukihisa (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Kubo Takuya (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Kaya Daisuke (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Tsuji Yuki (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Ozutsumi Takahiro (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Kitagawa Koh (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Mashitani Tsuyoshi (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Ogawa Hiroyuki (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Ishida Koji (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Mitoro Akira (Third Department of Internal Medicine, Nara Medical University, Nara, Japan) ,  Yamao Junichi (Department of Endoscopy, Nara Medical University Hospital, Nara, Japan) ,  Yoshiji Hitoshi (Third Department of Internal Medicine, Nara Medical University, Nara, Japan)
資料名： Hepatology Research  (Hepatology Research)
巻： 49  号： 2  ページ： 232-238  発行年： 2019年02月 
JST資料番号： W1284A  ISSN： 1386-6346  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： 目的:プロトンポンプ阻害剤(PPI)は肝硬変患者に処方される...

シソーラス用語： ヒト ,...
準シソーラス用語： Child-Pugh分類 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0419406&from=J-GLOBAL&jstjournalNo=W1284A") }}

著者キーワード (3件)： エンドトキシン活性アッセイ ,  肝硬変 ,  プロトンポンプ阻害剤

分類 (2件)： 消化器疾患の薬物療法  (GH05020G) ,  消化器作用薬の臨床への応用  (GW09020B)

タイトルに関連する用語 (7件)： 肝硬変 ,  患者 ,  プロトンポンプ阻害剤 ,  療法 ,  血清 ,  エンドトキシン ,  活性